Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Infracapital on the acquisition of Falbygdens Energi
Mandate

Vinge advises Infracapital on the acquisition of Falbygdens Energi

December 02, 2013

Vinge is advising Infracapital, a leading European infrastructure investor, managed by M&G Investment Management, the European investment management arm of Prudential plc in connection with the acquisition of Falbygdens Energi AB from Göteborg Energi AB.

Falbygdens Energi AB operates primarily within the Swedish municipality of Falköping. The business operations comprise mainly of the production and distribution of district heating and the distribution of electricity in the area. The electricity distribution network comprises 522 kilometres of overhead lines and 1,690 kilometres of underground cables. FEAB also operates a broadband business in the municipality.

Johan Göthberg was the responsible partner together with associates Matthias Pannier, Lisa Antman, Joel Zetterström, Gabriel Westin, Emma Kero Ljungberg and counsel Robert Deli. Partner Thomas Sjöberg and associate Sofia Ekdahl are advising on real estate and environmental questions.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025